Literature DB >> 9469685

Update: clinically significant cytochrome P-450 drug interactions.

E L Michalets1.   

Abstract

Recent technologies have resulted in an explosion of information concerning the cytochrome P-450 isoenzymes and increased awareness of life-threatening interactions with such commonly prescribed drugs as cisapride and some antihistamines. Knowledge of the substrates, inhibitors, and inducers of these enzymes assists in predicting clinically significant drug interactions. In addition to inhibition and induction, microsomal drug metabolism is affected by genetic polymorphisms, age, nutrition, hepatic disease, and endogenous chemicals. Of the more than 30 human isoenzymes identified to date, the major ones responsible for drug metabolism include CYP3A4, CYP2D6, CYP1A2, and the CYP2C subfamily.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9469685

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  92 in total

Review 1.  Drug interactions and the statins.

Authors:  R J Herman
Journal:  CMAJ       Date:  1999-11-16       Impact factor: 8.262

Review 2.  Drug-Drug interactions of clinical significance in the treatment of patients with Mycobacterium avium complex disease.

Authors:  J I Kuper; M D'Aprile
Journal:  Clin Pharmacokinet       Date:  2000-09       Impact factor: 6.447

3.  Drug Interactions Among the Antiretrovirals.

Authors:  Ian R. McNicholl
Journal:  Curr Infect Dis Rep       Date:  2004-04       Impact factor: 3.725

Review 4.  [Clinically relevant pharmacokinetic drug interactions in the intensive care unit: an overview].

Authors:  W Kämmerer
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-03-23       Impact factor: 0.840

5.  Analysis of genetic variations in CYP2C9, CYP2C19, CYP2D6 and CYP3A5 genes using oligonucleotide microarray.

Authors:  Yuanyuan Dong; Huasheng Xiao; Qi Wang; Chunxiu Zhang; Xiuming Liu; Na Yao; Haihui Sheng; Haiyan Li
Journal:  Int J Clin Exp Med       Date:  2015-10-15

Review 6.  The role of P-glycoprotein and organic anion-transporting polypeptides in drug interactions.

Authors:  Lawrence M DuBuske
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 7.  Switching between second-generation antipsychotics: why and how?

Authors:  Monika Edlinger; Susanne Baumgartner; Nadja Eltanaihi-Furtmüller; Martina Hummer; W Wolfgang Fleischhacker
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

8.  Test-retest stability of cerebral A1 adenosine receptor quantification using [18F]CPFPX and PET.

Authors:  David Elmenhorst; Philipp T Meyer; Andreas Matusch; Oliver H Winz; Karl Zilles; Andreas Bauer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-01-23       Impact factor: 9.236

9.  Antiepileptic Drug Therapy in Migraine Headache.

Authors:  Steve D. Wheeler
Journal:  Curr Treat Options Neurol       Date:  2002-09       Impact factor: 3.598

10.  Quantitative drug interactions prediction system (Q-DIPS): a dynamic computer-based method to assist in the choice of clinically relevant in vivo studies.

Authors:  P Bonnabry; J Sievering; T Leemann; P Dayer
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.